0001438133-20-000141.txt : 20200917
0001438133-20-000141.hdr.sgml : 20200917
20200917175845
ACCESSION NUMBER: 0001438133-20-000141
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200916
FILED AS OF DATE: 20200917
DATE AS OF CHANGE: 20200917
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HANSEN BRIAN B
CENTRAL INDEX KEY: 0001542377
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36189
FILM NUMBER: 201182092
MAIL ADDRESS:
STREET 1: 10210 GENETIC CENTER DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC
CENTRAL INDEX KEY: 0001438133
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204327508
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11075 ROSELLE STREET
CITY: San Diego
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-366-6900
MAIL ADDRESS:
STREET 1: 11075 ROSELLE STREET
CITY: San Diego
STATE: CA
ZIP: 92121
4
1
wf-form4_160037990824721.xml
FORM 4
X0306
4
2020-09-16
0
0001438133
TANDEM DIABETES CARE INC
TNDM
0001542377
HANSEN BRIAN B
11075 ROSELLE ST
SAN DIEGO
CA
92121
0
1
0
0
EVP & CHIEF COMMERCIAL OFFICER
Common Stock
2020-09-16
4
M
0
10525
51.50
A
15190
D
Common Stock
2020-09-16
4
S
0
9414
112.8787
D
5776
D
Common Stock
2020-09-16
4
S
0
1111
114.0308
D
4665
D
Stock Option
51.5
2020-09-16
4
M
0
10525
0
D
Common Stock
10525.0
89489
D
Represents shares of common stock received upon exercise of a stock option award.
The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2020.
The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $112.75 and $113.59.The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $113.84 and $114.48. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The option vested as to twenty-five percent (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter.
The expiration date for these options is 10 years from the date of grant.
s/ David B. Berger, Attorney-in-Fact for Brian B. Hansen
2020-09-17